U.S. Consumer Finance Stock News

Wondering if Unity Software at around US$26.73 is offering fair value or if the stock price is out of sync with the business? This article walks through what the numbers are saying so you can judge that for yourself. The stock has returned 1.2% over the past week and 21.4% over the last 30 days, while year to date it shows a 39.6% decline and a 29.4% return over the past year, highlighting that sentiment around risk and potential has shifted more than once. Recent headlines have focused on...

If you are wondering whether BellRing Brands' current share price offers value or just more volatility, it helps to start with what the recent returns are actually telling you. The stock last closed at US$10.46, with returns of a 41.2% decline over 7 days, a 33.2% decline over 30 days, a 59.9% decline year to date and an 83.1% decline over the past year. This clearly changes how many investors think about its potential and its risks. Recent coverage has focused on how the company fits into...

BXP (NYSE:BXP) is relocating its regional headquarters to make room for major tenant the Washington Commanders in Foggy Bottom. The company is moving into a newly renovated downtown Washington, DC office building as part of this shift. The relocation aligns with recent leasing activity and capital deployment in the DC market. For investors watching NYSE:BXP, this move ties directly to how the company is using its portfolio to support active leasing and tenant relationships. The stock last...

Inovio Pharmaceuticals recently announced plans to release its Q1 2026 earnings after market close on May 13, 2026, alongside a conference call and upcoming scientific presentations on its DNA medicine pipeline for HPV-related diseases, cancer, and infectious diseases. Investor attention has intensified as Inovio’s DNA vaccine and gene transfer programs gain visibility, supported by significant institutional ownership and new clinical data disclosures on candidates such as INO-3107 and its...

Kestrel Group (KG) has wrapped up FY 2025 with fourth quarter revenue of US$10.2 million and a basic EPS loss of US$2.13, alongside net income from ongoing operations of a US$16.5 million loss and a US$1.4 million loss from discontinued operations. Over recent periods the company has seen quarterly revenue move from US$1.22 million in Q4 2024 to US$17.4 million in Q3 2025 and then US$10.2 million in Q4 2025. Basic EPS shifted from a small profit of US$0.02 in Q4 2024 to a sizeable profit of...

Why Patria Investments (PAX) is on investors’ radar today Patria Investments (PAX) has drawn attention after recent trading left the stock around $12.04, with returns showing mixed signals over the past week, month and past 3 months. See our latest analysis for Patria Investments. The recent 6.8% one day share price decline and 24.4% year to date share price loss contrast with a 9.8% one year total shareholder return. This suggests that recent momentum has faded even as income and past...

Korn Ferry (NYSE:KFY) has been named America’s Best Executive Recruiter by Forbes Magazine for the ninth time in ten years. The recognition highlights Korn Ferry’s position among the top professional search firms in the United States. Korn Ferry’s latest recognition comes as the stock trades at $67.14, with a 3.8% return over the past year and a 51.2% return over three years. The company’s track record in executive recruitment, reflected in this recurring award, helps frame NYSE:KFY as a...

Kennametal Inc. recently reported its fiscal 2026 third-quarter results, with sales rising to US$592.59 million and net income reaching US$58.23 million, while also raising full-year sales guidance to a range of US$2.33 billion to US$2.35 billion. Alongside the stronger earnings and upgraded outlook, the company affirmed a quarterly dividend of US$0.20 per share, highlighting management’s confidence in cash generation and balance sheet flexibility. We’ll now examine how Kennametal’s raised...

Celcuity's lead drug candidate, gedatolisib, produced positive Phase 3 results in the VIKTORIA-1 trial for PIK3CA-mutant HR+/HER2- metastatic breast cancer. The trial met its primary endpoint and showed a significant improvement in progression-free survival. Celcuity plans to submit a supplemental NDA to the FDA, with full data scheduled for presentation at ASCO 2026. The program follows an existing Priority Review for gedatolisib in the wild-type population, with an FDA decision...

Wondering whether Mattel at around US$15.00 is starting to look like value, or if the stock still has more to prove before it deserves a spot in your portfolio. The share price has moved about 0.5% lower over the last 7 days, after a 4.0% gain over the last 30 days, and is currently sitting on a 25.1% decline year to date and a 13.1% decline over the last year. These moves come as investors weigh up the latest developments around the business and its position in the wider toy and...

Alamo Group Inc. has released its first-quarter 2026 results, reporting sales and revenue of US$417.15 million, up from US$390.95 million a year earlier, while net income eased to US$29.18 million and diluted earnings per share from continuing operations slipped to US$2.41. The combination of higher sales but lower earnings highlights pressure on profitability, offering fresh context for how efficiently Alamo Group is converting growing demand into bottom-line results. We’ll now examine how...

If you are wondering whether SM Energy stock still offers value at its current level, it helps to step back and separate short term noise from long term pricing signals. The share price closed at US$29.10, with returns of 52.1% year to date and 32.1% over the last year, even as the stock saw a 6.2% decline over the past week and a 7.2% decline over the last month. Recent news coverage around SM Energy has largely focused on the company within broader energy sector themes and investor...

Wondering if Fifth Third Bancorp at around US$49.67 is offering real value or just riding sentiment? This article breaks down what the current price may be implying about the stock. The stock has recently shown mixed short term moves, with a 2.1% decline over the last 7 days, a 3.9% return over 30 days, a 4.1% return year to date, and a 38.1% return over the past year, alongside a 136.4% return over 3 years and a 42.7% return over 5 years. Recent coverage has focused on how established banks...

In early May 2026, Kodiak AI, Inc. closed a roughly US$100,000,000 private placement and reported first-quarter 2026 results showing higher sales and a move to net income, while advancing autonomous freight operations in the U.S., launching a Canadian timber pilot, and expanding into defense through a collaboration with General Dynamics Land Systems. Taken together, these moves highlight Kodiak’s push to apply its Kodiak Driver platform across long-haul trucking, industrial logistics and...

If you are wondering whether Allstate stock still offers value at its current level, the recent share performance and valuation checks provide some useful clues. The stock last closed at US$213.67, with returns of a 1.7% decline over 7 days, 1.5% over 30 days, 4.8% year to date, 7.5% over 1 year, 93.3% over 3 years, and 75.3% over 5 years. Recent news around Allstate has focused on broader industry questions such as pricing, claims costs, and the resilience of insurance balance sheets, which...

In the first quarter of 2026, Serve Robotics reported sales of US$2.98 million versus US$0.44 million a year earlier, but its net loss widened to US$49.0 million and loss per share to US$0.65, while reaffirming full‑year 2026 revenue guidance of about US$26.0 million. Beyond the headline numbers, Serve expanded its robot fleet to around 2,000 units across 44 cities and entered healthcare robotics through the acquisition of Diligent Robotics, highlighting a broader shift toward scaling...

Investors may be wondering whether Alpha Metallurgical Resources, at around US$193 a share, still offers value or if most of the opportunity has already been priced in. The stock has returned 3.7% over the last week, while the 30-day and year-to-date returns are a 5.1% decline and 4.7% decline, set against a 56.0% return over the past year and a very large gain over five years. Recent headlines have focused on Alpha Metallurgical Resources as part of the broader US materials sector, with...

If you are wondering whether MasTec at around US$412 per share is still priced attractively after a strong run, the next sections will focus squarely on what that price could mean for value. The stock has recently shown strong momentum, with returns of 4.6% over 7 days, 21.9% over 30 days, 81.1% year to date and 179.2% over the past year, and 353.7% and 253.0% over the past 3 and 5 years respectively. Recent coverage of MasTec has centered on its role in large infrastructure and energy...

Transfer activity puts Manchester United (MANU) in focus for investors Recent reports that Manchester United (MANU) is actively pursuing high profile signings, including Aurelien Tchouameni and Moises Kean, have turned attention to how an aggressive transfer approach could affect the listed club’s finances. See our latest analysis for Manchester United. The latest transfer speculation comes as Manchester United’s share price sits at $19.13, with a 1 month share price return of 9.5% and a year...

Are you wondering whether Tower Semiconductor's share price still makes sense after its recent run, or if you might be looking at a stock that has already priced in a lot of optimism? The stock trades at US$210.00 after a 5% decline over the past week, while sitting on a 10% return over 30 days, 72.5% year to date, and a 460.1% gain over the last year. Alongside this sharp move, investors have been reacting to broader interest in semiconductor stocks and shifting expectations about how Tower...

In April 2026, Xylem Inc. reported first-quarter revenue of US$2,125 million, net income of US$193 million, and diluted EPS of US$0.79, while also slightly raising its full-year 2026 revenue outlook to about US$9.20 billion–US$9.30 billion, implying 2%–3% reported growth. The combination of flat organic revenue against expectations and a higher full-year sales forecast highlights how project timing and resilient U.S. utility demand are shaping Xylem’s near-term performance and longer-term...

For readers wondering whether World Kinect is priced attractively right now or if the market has already factored in its potential, this article focuses squarely on what the current share price might be implying about value. World Kinect shares last closed at US$26.90, with returns of 14.1% over the past 30 days and 11.5% year to date, alongside a 4.5% return over the past year and 27.1% over three years, compared with a 5.3% decline across five years. Recent price moves sit against a...

NewAmsterdam Pharma (NAMS) drew fresh attention after reporting first quarter 2026 results that came in ahead of revenue and earnings estimates, while management highlighted several upcoming clinical and regulatory milestones. See our latest analysis for NewAmsterdam Pharma. The stock reacted sharply to the update, with a 1 day share price return of 12.46% and a 7 day share price return of 22.02%. This comes even though the year to date share price return is slightly negative, while the 1...

Six Flags Entertainment (NYSE:FUN) has announced several senior leadership changes, including a new Chief Marketing Officer from Carnival Cruise Line. The company has appointed a new Chief Legal and Compliance Officer joining from Dentons. An Interim Chief Financial Officer has stepped in following the resignation of the previous CFO. These appointments come as Six Flags Entertainment trades around $22.76, with recent moves in the stock that include a 21.2% return over the past week and...